YIDU TECH(02158)
Search documents
医渡科技(02158.HK)10月24日耗资12万港元回购2.1万股

Ge Long Hui· 2025-10-24 11:19
Core Viewpoint - The company, Yidu Tech (02158.HK), announced a share buyback on October 24, 2023, spending HKD 120,000 to repurchase 21,000 shares [1] Group 1 - The total expenditure for the share buyback was HKD 120,000 [1] - The number of shares repurchased in this transaction was 21,000 [1]
医渡科技(02158) - 翌日披露报表

2025-10-24 11:09
FF305 如上市發行人的已發行股份或庫存股份出現變動而須根據《香港聯合交易所有限公司(「香港聯交所」)證券上市規則》(「《主板上市規則》」)第13.25A條 / 《香港聯合交易所有限公司GEM證券 上市規則》(「《GEM上市規則》」)第17.27A條作出披露,必須填妥第一章節 。 | 第一章節 | | | | | | | | --- | --- | --- | --- | --- | --- | --- | | 1. 股份分類 | 普通股 | 股份類別 | 不適用 | 於香港聯交所上市 | 是 | | | 證券代號 (如上市) | 02158 | 說明 | | | | | | A. 已發行股份或庫存股份變動 | | | | | | | | | 事件 | | 已發行股份(不包括庫存股份)變動 | 庫存股份變動 | 每股發行/出售價 (註4) | 已發行股份總數 | | | | 已發行股份(不包括庫存股份)數 目 | 佔有關事件前的現有已發 行股份(不包括庫存股 份)數目百分比 (註3) | 庫存股份數目 | | | | 於下列日期開始時的結存(註1) | 2025年10月23日 | | 1,063,870,7 ...
股价被低估!医渡科技签订总回报掉期交易对冲升值风险
Zhi Tong Cai Jing· 2025-10-23 13:38
Core Viewpoint - The announcement by Yidu Tech (02158) regarding a total return swap transaction with Goldman Sachs indicates a strategic move to hedge against future stock price appreciation risks, reflecting management's optimistic outlook on the company's valuation potential [1] Group 1: Total Return Swap Transaction - Yidu Tech's subsidiary entered into a total return swap transaction with a nominal equity amount of HKD 54.4047 million, with a duration of approximately three years [1] - The purpose of this transaction is to mitigate the risk of stock price appreciation, particularly in relation to the potential costs and cash flow impacts associated with a share incentive plan post-IPO [1] Group 2: Stock Buyback and Valuation - Yidu Tech has been actively repurchasing shares, having bought back over 3.86 million ordinary shares at a total cost exceeding HKD 22 million since September 26 [1] - Analysts believe that the company's stock is significantly undervalued based on price-to-book ratios and the latest valuations of its international business and key asset reserves, excluding conservative estimates of domestic operations [1] Group 3: Management's Optimistic Outlook - The decision to enter into the total return swap transaction suggests that the management is optimistic about the company's future stock price appreciation potential [1] - By acquiring shares at a low point, the company aims to hedge against the risk of increased costs due to stock price appreciation, demonstrating a proactive risk management strategy [1]
股价被低估!医渡科技(02158)签订总回报掉期交易对冲升值风险
智通财经网· 2025-10-23 13:34
Core Viewpoint - The announcement by Yidu Tech (02158) regarding a total return swap transaction with Goldman Sachs indicates a strategic move to hedge against future stock price appreciation risks, reflecting management's optimistic outlook on the company's valuation potential [1] Group 1: Total Return Swap Transaction - Yidu Tech's subsidiary entered into a total return swap transaction with a notional amount of HKD 54.4047 million, with a duration of approximately three years [1] - The purpose of the transaction is to hedge against the risk of stock price appreciation, particularly in relation to the potential price increase associated with the stock incentive plan post-IPO [1] Group 2: Stock Buyback and Valuation - Yidu Tech has been actively repurchasing shares, having bought back over 3.86 million ordinary shares at a total cost exceeding HKD 22 million since September 26 [1] - Analysts believe that the company's stock is significantly undervalued based on price-to-book ratios and the latest valuations of its international business and key asset reserves, excluding conservative estimates of domestic operations [1] Group 3: Management's Optimistic Outlook - The decision to enter into the total return swap transaction suggests that the management is optimistic about the company's future stock price appreciation potential [1] - By acquiring shares at a low point, the company aims to mitigate the risk of increased costs due to stock price appreciation, showcasing a proactive risk management strategy [1]
医渡科技附属与总回报掉期对手方订立总回报掉期交易
Zhi Tong Cai Jing· 2025-10-23 13:12
Core Viewpoint - The company, Yidu Tech (02158), has announced a total return swap transaction with a nominal amount of approximately HKD 54.4047 million, aimed at hedging against future stock price appreciation risks [1] Group 1: Transaction Details - The total return swap transaction was established on October 23, 2025, with a maximum nominal amount of approximately HKD 54.4047 million, converted from USD at the current exchange rate on the announcement date [1] - The transaction is intended to mitigate the risks associated with potential increases in the company's stock price [1] Group 2: Strategic Rationale - The company faces increased costs and cash flow expenditures related to funding share purchases, which heightens the risk of stock price appreciation [1] - The board believes that entering into the total return swap transaction may help hedge against the price increase risks associated with shares purchased under the post-IPO share award plan [1]
医渡科技(02158)附属与总回报掉期对手方订立总回报掉期交易
智通财经网· 2025-10-23 13:07
Core Viewpoint - The company, Yidu Tech (02158), has announced a total return swap transaction with a nominal amount of approximately HKD 54.4047 million, aimed at hedging against future stock price appreciation risks [1] Group 1: Transaction Details - The total return swap transaction is set to be executed on October 23, 2025 [1] - The nominal amount of the transaction is approximately HKD 54.4047 million, converted from USD at the current exchange rate as of the announcement date [1] Group 2: Purpose of the Transaction - The company aims to hedge against the risk of stock price appreciation that may arise from costs and cash flow expenditures related to purchasing shares [1] - The board believes that entering into the total return swap transaction may help mitigate the price increase risk associated with shares acquired under the post-IPO share award plan [1]
医渡科技(02158) - 自愿性公告 - 总回报掉期

2025-10-23 12:58
香港交易及結算所有限公司及香港聯合交易所有限公司對本公告的內容概不負責,對其準確性或完整性亦不發表任何聲 明,並明確表示概不就因本公告全部或任何部分內容而產生或因依賴該等內容而引致的任何損失承擔任何責任。 Yidu Tech Inc. 醫渡科技有限公司 ( 於 開 曼 群 島 註 冊 成 立 的 有 限 公 司 ) (股份代號:2158) 自願性公告 總回報掉期 本公告乃由董事會自願作出。 總回報掉期 於2025年10月23日,本公司附屬公司與總回報掉期對手方訂立總回報掉期交易。總回報掉期 交易的最高股本名義金額約為54,404,700港元(根據本公告日期的現行匯率兌換自美元)。 為免生疑問,(i)總回報掉期交易的最高股本名義金額;及(ii)如本公司日期為2024年10月21 日、2024年10月28日及2025年4月25日的公告所公佈,截至本集團訂立的先前總回報掉期交 易(「先前總回報掉期交易」)初始執行期結束時的實際股本名義金額(「實際股本名義金額」)之 總和約為60,957,392.64港元。 總回報掉期交易的條款 根據總回報掉期交易的條款,總回報掉期交易期限約為三年。在符合若干條件的情況下,任 何一方 ...
医渡科技(02158)10月23日斥资194.02万港元回购35万股

智通财经网· 2025-10-23 11:55
智通财经APP讯,医渡科技(02158)发布公告,于2025年10月23日,该公司斥资194.02万港元回购35万股 股份,每股回购价格为5.47-5.6港元。 ...
医渡科技10月23日回购超194万港元,已连续5个交易日回购
Zhi Tong Cai Jing· 2025-10-23 11:46
根据医渡科技(02158)最新公告,公司于10月23日再次回购股份,单日斥资超194万港元购回35万股。 公开信息显示,医渡科技已连续5个交易日回购。9月26日至今,该股已完成9次回购,累计购回超386万 股普通股,累计回购金额超2200万港元。 另据最新数据,南向资金10月20日净买入医渡科技157.06万股,占当日成交量比例为19.69%。从增减持 金额来看,以增减持数量和成交均价为基准进行测算,南向资金当日净买入医渡科技888.96万港元,连 续7日净买入,累计净买入1.0亿港元。 消息面上,2025年"数据要素×"大赛江西分赛结果近日揭晓,医渡科技与南昌大学第一附属医院联合申 报的"医疗科研新基座:高质量数据集x垂域大模型双驱破障"项目,从全国1121支优秀团队中脱颖而 出,荣获医疗健康赛道一等奖。 ...
医渡科技(02158)10月23日回购超194万港元,已连续5个交易日回购
智通财经网· 2025-10-23 11:44
另据Wind最新数据,南向资金10月20日净买入医渡科技157.06万股,占当日成交量比例为19.69%。从 增减持金额来看,以增减持数量和成交均价为基准进行测算,南向资金当日净买入医渡科技888.96万港 元,连续7日净买入,累计净买入1.0亿港元。 消息面上,2025年"数据要素×"大赛江西分赛结果近日揭晓,医渡科技与南昌大学第一附属医院联合申 报的"医疗科研新基座:高质量数据集x垂域大模型双驱破障"项目,从全国1121支优秀团队中脱颖而 出,荣获医疗健康赛道一等奖。 智通财经APP获悉,根据医渡科技(02158)最新公告,公司于10月23日再次回购股份,单日斥资超194万 港元购回35万股。 公开信息显示,医渡科技已连续5个交易日回购。9月26日至今,该股已完成9次回购,累计购回超386万 股普通股,累计回购金额超2200万港元。 ...